Impact of enzalutamide on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives

@inproceedings{Luo2016ImpactOE,
  title={Impact of enzalutamide on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives},
  author={Jia Luo and Julie Nicole Graff},
  booktitle={Research and reports in urology},
  year={2016}
}
Prostate cancer claims the lives of more than 25,000 men in the United States yearly, most from metastatic disease. In the past decade, several new medications have been approved for the treatment of metastatic prostate cancer including the antiandrogen enzalutamide. In addition, there has been mounting interest in evaluating health-related quality of life (QoL) in patients with cancer including new more detailed recommendations released by the Prostate Cancer Working Group 3 on how to evaluate… CONTINUE READING
1 Citations
36 References
Similar Papers

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Similar Papers

Loading similar papers…